文献速递心境障碍会诊联络精神医学

多发性硬化中白质病灶与抑郁关系的网络映射

Mapping the Relationship of White Matter Lesions to Depression in Multiple Sclerosis.
PubMed 文献 · Biol Psychiatry · 2023-11-18

该研究基于380例多发性硬化(MS)患者的电子健康记录与3T结构MRI,比较抑郁组(n=232)与非抑郁组(n=148)的病灶负担。发现MS病灶优先累及抑郁网络内的纤维束,且抑郁组病灶负担更重,此差异由抑郁网络内病灶驱动。结论提示病灶位置与负担可能贡献于MS共病抑郁。

要点

  • MS病灶优先累及抑郁网络内纤维束(β=0.09,95%CI 0.08–0.10,p<.001)。
  • MS+抑郁组病灶负担高于MS-抑郁组(β=0.06,95%CI 0.01–0.10,p=.015)。
  • 组间病灶负担差异由抑郁网络内病灶驱动(β=0.02,95%CI 0.003–0.040,p=.020)。

核心结论

  • MS病灶位置与负担可能贡献于MS共病抑郁,病灶不成比例地影响抑郁网络内纤维束。

研究设计与样本

  • 利用电子健康记录识别380例MS患者,抑郁组232例(ICD-10抑郁诊断、抗抑郁药处方或PHQ-2/PHQ-9筛查阳性),年龄性别匹配的非抑郁组148例(无抑郁诊断、无精神科药物处方且PHQ-2/PHQ-9无症状)。
  • 作为常规诊疗的一部分获取研究质量3T结构MRI,评估病灶是否优先位于抑郁网络内以及两组病灶负担差异。

主要发现

  • MS病灶优先影响抑郁网络内而非网络外的纤维束(β=0.09,95%CI 0.08–0.10,p<.001)。
  • MS+抑郁组病灶负担高于MS-抑郁组(β=0.06,95%CI 0.01–0.10,p=.015)。
  • 组间病灶负担差异由抑郁网络内病灶驱动(β=0.02,95%CI 0.003–0.040,p=.020)。

关键数值与推荐

  • 抑郁组定义:ICD-10抑郁诊断、抗抑郁药处方或PHQ-2/PHQ-9筛查阳性。
  • 非抑郁组定义:无既往抑郁诊断、无精神科药物处方且PHQ-2/PHQ-9无症状。
  • 主要结局指标为网络内及全脑病灶负担(如受累纤维束)。

临床怎么用

  • 对MS患者评估抑郁时,可关注MRI病灶是否累及抑郁网络相关纤维束。
  • 抑郁网络内病灶负担较高的MS患者可能需要更积极的抑郁筛查与干预。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Multiple sclerosis (MS) is an immune-mediated neurological disorder, and up to 50% of patients experience depression. We investigated how white matter network disruption is related to depression in MS. METHODS: Using electronic health records, 380 participants with MS were identified. Depressed individuals (MS+Depression group; n = 232) included persons who had an ICD-10 depression diagnosis, had a prescription for antidepressant medication, or screened positive via Patient Health Questionnaire (PHQ)-2 or PHQ-9. Age- and sex-matched nondepressed individuals with MS (MS-Depression group; n = 148) included persons who had no prior depression diagnosis, had no psychiatric medication prescriptions, and were asymptomatic on PHQ-2 or PHQ-9. Research-quality 3T structural magnetic resonance imaging was obtained as part of routine care. We first evaluated whether lesions were preferentially located within the depression network compared with other brain regions. Next, we examined if MS+Depression patients had greater lesion burden and if this was driven by lesions in the depression network. Primary outcome measures were the burden of lesions (e.g., impacted fascicles) within a network and across the brain. RESULTS: MS lesions preferentially affected fascicles within versus outside the depression network (β = 0.09, 95% CI = 0.08 to 0.10, p < .001). MS+Depression patients had more lesion burden (β = 0.06, 95% CI = 0.01 to 0.10, p = .015); this was driven by lesions within the depression network (β = 0.02, 95% CI = 0.003 to 0.040, p = .020). CONCLUSIONS: We demonstrated that lesion location and burden may contribute to depression comorbidity in MS. MS lesions disproportionately impacted fascicles in the depression network. MS+Depression patients had more disease than MS-Depression patients, which was driven by disease within the depression network. Future studies relating lesion location to personalized depression interventions are warranted.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Baller EB, Sweeney EM, Cieslak M, et al. Mapping the Relationship of White Matter Lesions to Depression in Multiple Sclerosis. Biol Psychiatry. 2023. PMID: 37981178. doi:10.1016/j.biopsych.2023.11.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。